financial statements
The full income statement, balance sheet, and cash-flow statement for Quest Diagnostics Incorporated (DGX), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
As-reported fiscal years.
| Line item | Trend | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Income Statement | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Revenue | 11.0B YoY+11.8% | 9.87B YoY+6.7% | 9.25B YoY-6.4% | 9.88B YoY-8.4% | 10.8B YoY+14.3% | |
| Cost of revenue | 7.37B YoY+11.2% | 6.63B YoY+6.9% | 6.20B YoY-3.9% | 6.45B YoY-2.0% | 6.58B YoY+13.4% | |
| Selling, general & administrative | 1.97B YoY+11.1% | 1.77B YoY+7.8% | 1.64B YoY-12.4% | 1.87B YoY+8.5% | 1.73B YoY+11.4% | |
| Restructuring | — | — | — | 55.0M YoY+323.1% | 13.0M YoY-7.1% | |
| Amortization of intangibles | 154M YoY+21.3% | 127M YoY+17.6% | 108M YoY-10.0% | 120M YoY+16.5% | 103M YoY+0.0% | |
| Provision for credit losses | — | 5.00M YoY+400.0% | 1.00M YoY-66.7% | 3.00M YoY-25.0% | 4.00M YoY-78.9% | |
| Operating income | 1.56B YoY+15.6% | 1.35B YoY+6.7% | 1.26B YoY-11.6% | 1.43B YoY-40.0% | 2.38B YoY+20.8% | |
| Interest expense | — | — | 163M YoY+10.1% | 148M YoY-2.6% | 152M YoY-8.4% | |
| Interest & investment income | 13.0M YoY-48.0% | 25.0M YoY+127.3% | 11.0M YoY+10.0% | 10.0M YoY+900.0% | 1.00M YoY-66.7% | |
| Net interest income | -264M YoY-31.3% | -201M YoY-32.2% | -152M YoY-10.1% | -138M YoY+8.6% | -151M YoY+7.4% | |
| Other non-operating income | 26.0M YoY-13.3% | 30.0M YoY+50.0% | 20.0M YoY+136.4% | -55.0M YoY-114.9% | 369M YoY+385.5% | |
| Equity-method income | 42.0M YoY+121.1% | 19.0M YoY-26.9% | 26.0M YoY-40.9% | 44.0M YoY-43.6% | 78.0M YoY+4.0% | |
| Pre-tax income | 1.32B YoY+12.2% | 1.18B YoY+4.0% | 1.13B YoY-8.5% | 1.24B YoY-52.5% | 2.60B YoY+38.0% | |
| Income tax | 314M YoY+15.0% | 273M YoY+10.1% | 248M YoY-6.1% | 264M YoY-55.8% | 597M YoY+29.8% | |
992M YoY+13.9% | 871M YoY+2.0% | 854M YoY-9.7% | 946M YoY-52.6% | 2.00B YoY+39.4% | ||
$8.75 YoY+13.8% | $7.69 YoY+2.7% | $7.49 YoY-6.0% | $7.97 YoY-48.7% | $15.55 YoY+48.5% | ||
| Balance Sheet | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
2.38B YoY-0.6% | 2.39B YoY+0.8% | 2.37B YoY+25.0% | 1.90B YoY-30.8% | 2.74B YoY-10.4% | ||
16.2B YoY+0.4% | 16.2B YoY+15.2% | 14.0B YoY+9.2% | 12.8B YoY-5.7% | 13.6B YoY-3.0% | ||
2.28B YoY+5.0% | 2.17B YoY+19.5% | 1.81B YoY+17.0% | 1.55B YoY-11.5% | 1.75B YoY-1.3% | ||
| Long-term debt | 5.17B YoY-8.0% | 5.62B YoY+27.3% | 4.41B YoY+10.9% | 3.98B YoY-0.8% | 4.01B YoY-0.1% | |
| Non-current lease liability | 537M YoY+0.4% | 535M YoY+6.4% | 503M YoY+2.9% | 489M YoY-1.0% | 494M YoY-1.0% | |
| Deferred tax liabilities | 264M YoY+0.0% | 264M YoY+0.0% | 264M YoY+0.0% | 264M YoY+0.0% | 264M YoY+0.0% | |
| Other non-current liabilities | 957M YoY+2.0% | 938M YoY+7.1% | 876M YoY+7.9% | 812M YoY+2.5% | 792M YoY-6.5% | |
7.17B YoY+5.8% | 6.78B YoY+7.5% | 6.31B YoY+7.0% | 5.89B YoY-8.6% | 6.44B YoY-4.7% | ||
| Cash Flow | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
1.89B YoY+41.4% | 1.33B YoY+4.9% | 1.27B YoY-26.0% | 1.72B YoY-23.1% | 2.23B YoY+11.4% | ||
-631M YoY+75.2% | -2.55B YoY-140.2% | -1.06B YoY-95.4% | -543M YoY-2685.7% | 21.0M YoY+102.7% | ||
-1.39B YoY-228.0% | 1.08B YoY+577.5% | 160M YoY+109.2% | -1.73B YoY+31.8% | -2.54B YoY-100.5% | ||
| FX effect on cash | 4.00M YoY+157.1% | -7.00M | 0.00 | 0.00 | — | |
| Net change in cash | -129M YoY+5.8% | -137M YoY-136.9% | 371M YoY+166.6% | -557M YoY-94.8% | -286M | |
| Interest paid | 280M YoY+6.9% | 262M YoY+95.5% | 134M YoY-14.1% | 156M YoY-1.9% | 159M YoY-20.9% | |
| Income taxes paid | 169M YoY-34.0% | 256M YoY-19.2% | 317M YoY+12.0% | 283M YoY-60.1% | 709M YoY+96.9% | |
| Valuation Ratios | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Market cap | 19.3B YoY+14.6% | 16.8B YoY+8.6% | 15.5B YoY-13.0% | 17.8B YoY-16.1% | 21.2B YoY+32.2% | |
| P/E | 19.5× YoY+0.7% | 19.3× YoY-4.7% | 20.3× YoY+37.3% | 14.8× YoY+38.8% | 10.6× YoY-5.2% | |
| P/S | 1.7× YoY+2.6% | 1.7× YoY+2.5% | 1.7× YoY-6.1% | 1.8× YoY-9.9% | 2.0× YoY+15.6% | |
| P/B | 2.7× YoY+8.4% | 2.5× YoY+3.1% | 2.4× YoY-17.7% | 2.9× YoY-11.2% | 3.3× YoY+38.6% | |
| P/FCF | 14.2× YoY-23.3% | 18.5× YoY-28.7% | 26.0× YoY+108.4% | 12.5× YoY+7.4% | 11.6× YoY+14.6% | |
| Earnings yield | 5.1% YoY-0.7% | 5.2% YoY+4.9% | 4.9% YoY-27.2% | 6.8% YoY-28.0% | 9.4% YoY+5.5% | |
| FCF yield | 7.0% YoY+30.4% | 5.4% YoY+40.2% | 3.9% YoY-52.0% | 8.0% YoY-6.9% | 8.6% YoY-12.7% | |
| Source filing | 10-K | 10-K | 10-K | 10-K | 10-K |
About this data
Source: DGX's SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn't file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all DGX filings on SEC EDGAR → Not investment advice.